UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Use of Intestinal Ultrasound to Monitor Crohn’s Disease Activity

Clinical gastroenterology and hepatology, 2017-04, Vol.15 (4), p.535-542.e2

2017

Volltextzugriff (PDF)

Diagnosis of small bowel Crohn’s disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis

Gut, 2005-12, Vol.54 (12), p.1721-1727

2005

Volltextzugriff (PDF)

Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program

Inflammatory bowel diseases, 2015-03, Vol.21 (3), p.579-588

2015

Volltextzugriff (PDF)

Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long‐term extension data from a Phase 3 study

Alimentary pharmacology & therapeutics, 2016-08, Vol.44 (3), p.259-270

2016

Volltextzugriff (PDF)

Vedolizumab induction therapy for inflammatory bowel disease in clinical practice – a nationwide consecutive German cohort study

Alimentary pharmacology & therapeutics, 2016-05, Vol.43 (10), p.1090-1102

2016

Volltextzugriff (PDF)

Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

The New England journal of medicine, 2012-10, Vol.367 (16), p.1519-1528

2012

Volltextzugriff (PDF)

Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data

The American journal of gastroenterology, 2010-07, Vol.105 (7), p.1574-1582

2010

Volltextzugriff (PDF)

Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left‐sided ulcerative colitis

Alimentary pharmacology & therapeutics, 2010-08, Vol.32 (3), p.368-376

2010

Volltextzugriff (PDF)

Dronedarone, amiodarone and other antiarrhythmic drugs, and acute liver injuries: a case-referent study

International journal of cardiology, 2018-09, Vol.266, p.100-105

2018

Volltextzugriff (PDF)

Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months

Clinical gastroenterology and hepatology, 2010-07, Vol.8 (7), p.600-609

2010

Volltextzugriff (PDF)

P501 Baseline characteristics of Crohn's disease patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (02)

Journal of Crohn's and colitis, 2017-02, Vol.11 (suppl_1), p.S333-S334

2017

Volltextzugriff (PDF)

P337 TNF-alpha as induction therapy for Crohn's disease: a comparison of adalimumab and infliximab – a prospective observational study in Germany

Journal of Crohn's and colitis, 2014-02, Vol.8, p.S205-S205

2014

Volltextzugriff (PDF)

3 Anti-TNF in patients with an early course of Crohn's disease – a prospective observational study in Germany

Journal of Crohn's and colitis, 2013-02, Vol.7, p.S2-S2

2013

Volltextzugriff (PDF)

Adherence to the H1N1 vaccination recommendation in patients with Crohn's disease or ulcerative colitis

Deutsche medizinische Wochenschrift (1946), 2011-05, Vol.136 (18), p.939

German IBD Study Group

2011

Volltextzugriff (PDF)

Improving relapse prediction in inflammatory bowel disease by neutrophil-derived S100A12

Inflammatory bowel diseases, 2013-05, Vol.19 (6), p.1130-1138

2013

Volltextzugriff (PDF)

Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 Versus prednisolone in active crohn's disease

The American journal of gastroenterology, 2006-04, Vol.101 (4), p.793-797

2006

Volltextzugriff (PDF)

Erfolgsfaktoren Im Dialogmarketing: Eine Empirische Analyse Unter Berucksichtigung Von B-to-b- Und B-to-c-unternehmen

Krummenerl, Markus

2005., 2012

Volltextzugriff (PDF)

Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active crohn's disease

Gastroenterology (New York, N.Y. 1943), 2001-05, Vol.120 (6), p.1339-1346

2001

Volltextzugriff (PDF)

Early MOnitoring of REsponse (MORE) to Golimumab Therapy: Results of a Multicentre, Prospective Observational Trial

Digestive diseases (Basel), 2023, Vol.41 (2), p.239-249

2023

Volltextzugriff (PDF)

Su1382 Adalimumab and Infliximab As Induction Therapy for Crohn's Disease -A Prospective Observational Study in Germany

Gastroenterology (New York, N.Y. 1943), 2014-05, Vol.146 (5), p.S-453-S-453

2014

Volltextzugriff (PDF)

Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency

European journal of drug metabolism and pharmacokinetics, 2017-04, Vol.42 (2), p.229-238

2017

Volltextzugriff (PDF)

Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I f (funny channel current) inhibitor ivabradine: MODI fY Trial

Clinical research in cardiology, 2011-10, Vol.100 (10), p.915-923

2011

Volltextzugriff (PDF)

Advanced-stage syphilis unmasking after immunomodulator therapy in a patient with ulcerative colitis

The American journal of gastroenterology, 2012-01, Vol.107 (1), p.144-145

2012

Volltextzugriff (PDF)

Health care for osteoporosis in inflammatory bowel disease: Unmet needs in care of male patients?

Journal of Crohn's and colitis, 2013-12, Vol.7 (11), p.901-907

2013

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(40)
Berichte
(2)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of Intestinal Ultrasound to Monitor Crohn’s Disease Activity

Diagnosis of small bowel Crohn’s disease: a prospective comparison of capsule endoscopy with magnetic resonance imaging and fluoroscopic enteroclysis

Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program

Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long‐term extension data from a Phase 3 study

Vedolizumab induction therapy for inflammatory bowel disease in clinical practice – a nationwide consecutive German cohort study

Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data

Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left‐sided ulcerative colitis

Dronedarone, amiodarone and other antiarrhythmic drugs, and acute liver injuries: a case-referent study

Continuous Therapy With Certolizumab Pegol Maintains Remission of Patients With Crohn's Disease for up to 18 Months

P501 Baseline characteristics of Crohn's disease patients in the vedolizumab PASS study: a cohort study assessing the safety and effectiveness of vedolizumab compared to other biologic agents (02)

P337 TNF-alpha as induction therapy for Crohn's disease: a comparison of adalimumab and infliximab – a prospective observational study in Germany

3 Anti-TNF in patients with an early course of Crohn's disease – a prospective observational study in Germany

Adherence to the H1N1 vaccination recommendation in patients with Crohn's disease or ulcerative colitis

Improving relapse prediction in inflammatory bowel disease by neutrophil-derived S100A12

A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis

Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 Versus prednisolone in active crohn's disease

Erfolgsfaktoren Im Dialogmarketing: Eine Empirische Analyse Unter Berucksichtigung Von B-to-b- Und B-to-c-unternehmen

Absence of efficacy of subcutaneous antisense ICAM-1 treatment of chronic active crohn's disease

Early MOnitoring of REsponse (MORE) to Golimumab Therapy: Results of a Multicentre, Prospective Observational Trial

Su1382 Adalimumab and Infliximab As Induction Therapy for Crohn's Disease -A Prospective Observational Study in Germany

Randomized Open-Label Phase 1 Study of the Pharmacokinetics of Ferric Maltol in Inflammatory Bowel Disease Patients with Iron Deficiency

Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I f (funny channel current) inhibitor ivabradine: MODI fY Trial

Advanced-stage syphilis unmasking after immunomodulator therapy in a patient with ulcerative colitis

Health care for osteoporosis in inflammatory bowel disease: Unmet needs in care of male patients?

Suchergebnisse filtern